Listar O - Articles científics por fecha de publicación

Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights

Dienstmann, Rodrigo; Elez Fernandez, Mª Elena; Argilés Martinez, Guillem; Matos Garcia, Ignacio; Sanz Garcia, Enrique; Ortiz Velez, Carolina; Macarulla Mercadé, Teresa; Capdevila Castillon, Jaume; Alsina Maqueda, Maria; Sauri Nadal, Tamara; Verdaguer Mata, Helena; Ruiz Pace, Fiorella; Viaplana Donato, Cristina; Landolfi, Stefania; García Palmer, Héctor; Nuciforo, Paolo Giovanni; Rodon Ahnert, Jordi; Vivancos Prellezo, Ana; Tabernero Caturla, Josep (Wiley, 2017-06-15)

SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018)

González del Alba, A.; De Velasco, G.; Lainez, N.; Maroto, P.; Morales Barrera, Rafael; Muñoz‑Langa, J. (Springer, 2019-01)

Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy

Zandberg, Dan P.; Algazi, Alain P.; Jimeno, Antonio; Good, James S.; Fayette, Jérôme; Bouganim, Nathaniel; Braña Garcia, Irene (Elsevier, 2019-01)

SEOM clinical guidelines in advanced and recurrent breast cancer (2018)

Chacón López‑Muñiz, J. I.; de la Cruz-Merino, Luis; Gavilá Gregori, Joaquín; Martínez Dueñas, E.; Antunes de Melo Oliveira, Ana Mafalda; Seguí Palmer, M. A.; Bellet Ezquerra, Meritxell (Springer, 2019-01)

Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study

Yoshino, T.; Portnoy, D. C.; Obermannova, Radka; Bodoky, György; Prausová, J.; Garcia-Carbonero, Rocio; Tabernero Caturla, Josep (Oxford University Press, 2019-01-01)

Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA

Gao, Meiling; Callari, Maurizio; Beddowes, Emma; Sammut, Stephen-John; Grzelak, Marta; Biggs, Heather; Cortés Castan, Javier; Antunes de Melo Oliveira, Ana Mafalda (BMC, 2019-01-04)

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

Heidenreich, Axel; Gillessen, Silke; Heinrich, Daniel; Keizman, Daniel; O'Sullivan, Joe M; Carles Galceran, Joan (BMC, 2019-01-07)

Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial

Gavilá Gregori, Joaquín; Antunes de Melo Oliveira, Ana Mafalda; Pascual, Tomás; Pérez García, José; Gonzàlez, Xavier; Canes, Jordi (BMC, 2019-01-09)

Cancer Core Europe: A translational research infrastructure for a European mission on cancer

Eggermont, Alexander M M; Apolone, Giovanni; Baumann, Michael; Caldas, Carlos; Celis, Julio E; Lorenzo, Francesco de; Tabernero Caturla, Josep (Wiley Open Access, 2019-01-18)

Shared heritability and functional enrichment across six solid cancers

Jiang, Xia; Finucane, Hilary K; Schumacher, Fredrick R; Schmit, Stephanie L; Tyrer, Jonathan; Han, Younghun; Diez Gibert, Orland (Nature Research, 2019-01-25)

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines

Vitiello, Pietro Paolo; Cardone, Claudia; Martini, Giulia; Ciardiello, Davide; Belli, Valentina; Matrone, Nunzia (BMC, 2019-01-28)

New clinical trial designs in the era of Precision Medicine

Garralda Cabanas, Elena; Dienstmann, Rodrigo; Piris Giménez, Alejandro; Braña Garcia, Irene; Rodon Ahnert, Jordi; Tabernero Caturla, Josep (Wiley Open Access, 2019-01-30)

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

Serrano Garcia, César; Mariño-Enríquez, Adrián; Tao, Derrick L.; Ketzer, Julia; Eilers, Grant; Zhu, Meijun (Nature Publishing Group, 2019-03)

Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer

Conteduca, Vincenza; Jayaram, Anuradha; Romero-Laorden, Nuria; Wetterskog, Daniel; Salvi, Samanta; Gurioli, Giorgia; Morales Barrera, Rafael (Elsevier, 2019-03)

Hydrodynamic and Electrophoretic Properties of Trastuzumab/HER2 Extracellular Domain Complexes as Revealed by Experimental Techniques and Computational Simulations

Ramos, Javier; Vega, Juan Francisco; Cruz, Victor; Sanchez-Sanchez, Eduardo; Cortés Castan, Javier; Martinez-Salazar, Javier (MDPI, 2019-03-01)

An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

Carles Galceran, Joan; Pichler, Angelika; Korunkova, Hana; Tomova, Antoaneta; Ghosn, Marwan; El Karak, Fadi (Wiley, 2019-03-01)

HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503

Gorbatenko, Andrej; Søkilde, Rolf; Sorensen, Ester E.; Newie, Inga; Persson, Helena; Morancho Armisen, Beatriz; Arribas López, Joaquin Vicente (Nature Publishing Group, 2019-03-04)

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology

Giuliani, Rosa; Tabernero Caturla, Josep; Cardoso, Fatima; McGregor, Keith Hanson; Vyas, Malvika; de Vries, Elisabeth (BMJ, 2019-03-06)

Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer

Rodriguez Freixinos, Victor; Ruiz Pace, Fiorella; Fariñas Madrid, Lorena; Garrido-Castro, Ana Christina; Villacampa Javierre, Guillermo; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Dienstmann, Rodrigo; Oaknin benzaquen, Ana Mazaltob (BMJ, 2019-03-08)

The Medical Oncology resident mentor: situation and workload

Elez Fernandez, Mª Elena; Quintanar, T.; Bosch-Barrera, J; Corral, J.; Lainez, N.; Moreno, Victor (Springer, 2019-03-08)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Listar VHIO - Articles científics por fecha de publicación

Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights

SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018)

Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy

SEOM clinical guidelines in advanced and recurrent breast cancer (2018)

Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study

Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial

Cancer Core Europe: A translational research infrastructure for a European mission on cancer

Shared heritability and functional enrichment across six solid cancers

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines

New clinical trial designs in the era of Precision Medicine

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer

Hydrodynamic and Electrophoretic Properties of Trastuzumab/HER2 Extracellular Domain Complexes as Revealed by Experimental Techniques and Computational Simulations

An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology

Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer

The Medical Oncology resident mentor: situation and workload

Conoce Scientia

Guies y ayudas

Directo a...

Conoce Scientia

Guies y ayudas

Directo a...

Listar VHIO - Articles científics por fecha de publicación

Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights ﻿

SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018) ﻿

Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy ﻿

SEOM clinical guidelines in advanced and recurrent breast cancer (2018) ﻿

Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study ﻿

Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA ﻿

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program ﻿

Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial ﻿

Cancer Core Europe: A translational research infrastructure for a European mission on cancer ﻿

Shared heritability and functional enrichment across six solid cancers ﻿

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines ﻿

New clinical trial designs in the era of Precision Medicine ﻿

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours ﻿

Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer ﻿

Hydrodynamic and Electrophoretic Properties of Trastuzumab/HER2 Extracellular Domain Complexes as Revealed by Experimental Techniques and Computational Simulations ﻿

An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA) ﻿

HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503 ﻿

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology ﻿

Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer ﻿

The Medical Oncology resident mentor: situation and workload ﻿

Conoce Scientia

Guies y ayudas

Directo a...

Conoce Scientia

Guies y ayudas

Directo a...

Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights

SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018)

Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy

SEOM clinical guidelines in advanced and recurrent breast cancer (2018)

Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study

Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial

Cancer Core Europe: A translational research infrastructure for a European mission on cancer

Shared heritability and functional enrichment across six solid cancers

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines

New clinical trial designs in the era of Precision Medicine

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer

Hydrodynamic and Electrophoretic Properties of Trastuzumab/HER2 Extracellular Domain Complexes as Revealed by Experimental Techniques and Computational Simulations

An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology

Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer

The Medical Oncology resident mentor: situation and workload